VIPVIZA
diabetes
CVD, BLOOD, PLAQUE, DIABETES
In total, 4177 VIP participants were invited to the VIPVIZA study, and participation rate was 84.6% (At baseline and three-year follow-up in VIPVIZA, participants responded to a questionnaire covering life style habits, medication, psychosocial situation and family history of CVD and diabetes. Blood pressure and anthropometric measurements were taken, and blood samples were collected to measure lipids and blood sugar. Participants also responded to validated psychometric questionnaires. The intervention group, and their primary care physicians, received a letter with a pictorial presentation of the ultrasound result.Intima-media thickness (IMT) was communicated as vascular age, where the individual’s IMT was compared to individuals with the same sex and age in a reference population [Graphical elements of the result letter, sent to participants in the intervention group after the ultrasound examination of carotid arteries, including information on plaque and intima media thickness.Clinical risk factors were measured again at one-year follow-up, and all participants and their primary care physician were given the results. At three-year follow-up, when the participants again were examined with ultrasound and the full baseline routine of validated questionnaires and measurements, the intervention group also responded to questions on reactions to the intervention at baseline. After this visit, all participants received a letter with a pictorial presentation of their ultrasound result. The complete study protocol is available at 